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Abstract 
The role of intracellular free Ca” concentration ([Ca”],) in cellular regulation of endothelin-I (ET-l) secretion was investigated in cultured porcine 
aortic endothelial cells of first passage. Intracellular Cal’ concentrations were adjusted between 50 nM and 1 PM using EGTA and thapsigargin, 
respectively. ET-l secretion was maximal at [Ca”], of 19&470 nM, and reduced at low (50 and 110 nM) and high (>470 nM) [Ca”],. The Ca*’ 
ionophores A23187 and ionomycin (each 1 PM), both of which raise [Ca”], above 1 ,uM, also potently inhibited ET-I secretion under basal and 
stimulated conditions. The A23187-induced reduction in ET-l secretion was not affected by fl-nitro-L-arginine (0.1 mM). Our results provide 
evidence that basal ET-l secretion is regulated by Ca*’ and that Ca2’ ionophores reduce ET-l secretion due to the inhibitory effect of high [Ca*‘],. 
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1. Introduction 
The endothelins (ET) are recently discovered en- 
dogenous polypeptides with multiple biologic actions [l]. 
Endothelins are produced by cultured and native endo- 
thelial cells [2], isolated tissues and whole organs [3-51 
under basal conditions and in response to a variety of 
chemical stimuli, including thrombin [6,7] and pressor 
hormones [8]. The second messengers governing ET se- 
cretion are not well understood. Since several of these 
stimuli elevate the intracellular free Ca2+ concentration, 
Ca*’ may mediate the action of these agents. This is 
supported by the finding that Ca*’ ionophores induce a 
time-dependent increase in ET-l secretion [8,9] and en- 
dothelial prepro-ET-l mRNA expression after short in- 
cubation periods [lo]. Recently, however, the Ca2’ iono- 
phore A23 187 was shown to inhibit rather than stimulate 
ET-l secretion [ll], and the Ca2’ channel blocker ni- 
soldipine reduced basal ET-l secretion from cultured 
endothelial cells in a concentration-dependent manner 
[12]. The goal of the present study was to determine the 
dependence of ET-l release on [Ca2+]i in cultured endo- 
thelial cells, whose Ca2’ concentration was adjusted to 
different levels. Since high Ca2’ levels maintained for 
extended periods of time are toxic, particular attention 
was paid to cell viability. We present evidence that basal 
ET-l secretion is close to maximal at physiological 
*Corresponding author. Fax: (43) (316) 323-5414. 
Abbreviations: EGTA, ethylene glycol-his@-aminoethyl ether)- 
N,N.N,K-tetraacetic acid; Fura-Z/AM, penta-acetoxymethyl ester of 
fura-2; HEPES, N-[2-hydroxyethyllpiperazine-N-[ethanesulfonic acid]; 
[Ca’+],, intracellular free Ca” concentration(s); L-NNA, NG-nitro-r- 
arginine; PMA, phorbol 12-myristate 13-acetate. 
[Ca*+]i but reduced at low 
to inhibition of synthesis. 
2. Materials and methods 
2.1. Materials 
and high concentrations due 
[3-(‘*‘I)Tyr]-ET-1 (specific activity -2,000 Ci/mmol) was from 
ANAWA Trading, Wangen, Switzerland. Fura-2/AM was from 
Lambda Probes and Diagnostics, Graz, Austria. The source of all other 
chemicals and tissue culture media was described previously [13]. Con- 
centrations are expressed as final molar concentrations in the buffered 
incubation medium. 
2.2. Cell culture 
Porcine aortic endothelial cells were isolated according to the method 
of Sturek et al. [14] and cultured as previously described [13]. Only 
confluent cultures of endothelial cells (- 1 06cells per well, or - 10’ cells per 
cm’) of first passage (-10 days after isolation) were used. For each 
experiment, aseparate preparation derived from the pooled cells of 1-3 
aortae was used. Confluent cells were incubated in fresh Dulbecco’s 
minimum essential medium (DMEM) without serum for 3 h together 
with all agents. Following incubation the media were harvested, the 
cells lysed, and the ET-I concentration determined by radioimmunoas- 
say (RIA). Cell viability was judged: (i) by optical inspection; (ii) in 
terms of lactate dehydrogenase (LDH) release into cell-conditioned 
medium; and (iii) using the calorimetric MTT (tetrazolium) assay devel- 
oped by Mosmann [15] as modified in the EZ4U-test (Biomedica, 
Vienna, Austria). 
2.3. Cd’ measurement 
[Ca”], was measured with the fura- technique using a dual wave- 
length temperature-controlled spectrofluorimeter (Shimadzu Rf 5000/ 
PC, Shimadzu Corp., Vienna, Austria). Confluent endothelial cells 
were harvested by incubation with protein buffered saline (PBS) con- 
taining 0.05% trypsin and 0.02% EDTA for 2 min, the suspension 
centrifuged, the supernatant aspirated, and the cells resuspended for 45 
min in DMEM containing all agents used to adjust [Ca”],. Following 
this, 2 .uM fura-Z/AM were added for 40 min. Cells were centrifuged, 
the medium discarded, and the cells resuspended in HEPES buffer 
(-1 x IO6 cells per ml), again containing all agents used to adjust 
the intracellular Ca” concentration. Ca*’ determinations were carried 
out on separate plates of cells derived from the same aorta(e) as those 
which were used for ET-I determinations. Fura- fluorescence was 
monitored at 37°C by the ratio fluorescence spectroscopy at least 
I .5 h after arranging the various Ca*’ concentrations (excitation at 340 
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and 380 nm, emission at 500 nm). Autofluorescence was corrected and 
[Ca’+], calculated according to Grynkiewicz et al [16]. 
2.4. Measurement of ET-I 
Endothelin-I was measured by RIA using an antibody specific for 
ET-l (RAS 6901, Peninsula Laboratories, Belmont, CA, USA). Sam- 
ples and standards (0.1 ml) were incubated with 0.1 ml assay buffer 
containing anti-ET-l antibody for 24 h at room temperature. The 
radioactive tracer, [3-(“‘I)Tyr]-ET-l (specific activity -2,000 CYmmol, 
10,000 cpmltube), was added at the same time as the antibody. To 
terminate incubation, 0.1 ml y-globulin (11 mg/ml RIA buffer) and 0.75 
ml polyethylene glycol 6,000 (20% in water) was added, the mixture 
allowed to stand for 5 min at room temperature, and centrifuged for 
20 min at 3,000 x g to separate bound from free radioactivity. The 
supernatant was decanted and the pellet counted in a gamma counter 
(Packard-Canberra, Vienna, Austria). The intra- and inter-assay coeffi- 
cients of variation were determined with 3.0 pg ET-I assayed 4 times 
in one run and in 4 different runs and were 5.0 and 5.8%, respectively. 
2.5. Stalistical analysis 
Data are presented as arithmetic means 5 S.E.M. Differences were 
tested for statistical significance using Student’s unpaired r-test. A 
P-value ~0.05 was considered to be significant. P-values SO.01 or 
lower were not indicated separately. Numbers of experiments (n) refer 
to different cell cultures. 
3. Results 
Fig. 1 illustrates the cumulative basal ET-l release 
from confluent endothelial cells and ET-l levels within 
cells as a function of time under control conditions (1.8 
mM extracellular Ca2’). Only a small fraction of ET-l 
accumulated within cells (17%), the greater portion 
(83%) was released into the culture medium. The concen- 
tration in conditioned medium after 3 h of incubation 
was 295 + 22 pg ET-l per lo6 cells. In the presence of 
phorbol 12-myristate 13-acetate (PMA; 0.4 ,uM), ET-l 
levels in the culture medium increased by 36% (3 h, 
P < 0.05), whereas intracellular levels were not affected. 
To adjust [Ca”], of cells to different levels, plates of 
endothelial cells were incubated at different Ca*’ concen- 
trations as shown in Fig. 2. An extracellular Ca” con- 
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Fig. I. Time-dependence of cumulative ET-I secretion into culture 
medium and accumulation in endothelial cells under basal conditions 
and in the presence of phorbol l2-myristate 13-acetate (PMA; 0.4pM). 
Extracellular Ca*’ concentration was 1.8 mM. Data are 
means + S.E.M. of 3 or 6 experiments. The effect of PMA on ET-I- 
secretion from cells was significant. 
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Fig. 2. Adjustment of intracellular free Ca*’ concentration using 
EGTA, thapsigargin (TG) and CaCI, at the concentrations indicated. 
[Ca”‘], was measured by the ratio technique I.5 h after addition of 
agents. Data are means f S.E.M. of 7 different determinations. All 
values were different from control (1.8 mM extracellular Ca”). 
centration of 1.8 mM (control) resulted in a mean resting 
[Ca*‘]i of 190 nM. Addition of EGTA (5 mM) or EGTA 
(1.7 mM) plus thapsigargin (10 nM) [ 171 to control incu- 
bation medium reduced intracellular Ca” to 50 and 110 
nM, respectively, whereas higher extracellular Ca” (1.8 
mM or 5.0 mM) and/or thapsigargin concentrations (1 O- 
100 nM) increased [Ca”], up to - 1 PM. The Ca2’ iono- 
phores A23187 and ionomycin (1 ,uM) increase [Ca2’], 
above 1 ,uM [18]. ET-l secretion at these different intra- 
cellular Ca2+ concentrations is shown in Fig. 3. At 190 
nM (control), ET-l secretion was maximal, but reduced 
to -50% of control at both the lowest and highest Ca” 
concentrations, thus resulting in a bell-shaped relation- 
ship between ET-l secretion and [Ca”],. In the presence 
of A23187 (1 PM), inhibition of ET-l secretion was in- 
distinguishable (- 50%) from that at a 10 times lower Ca2’ 
concentration. A second Ca2’ ionophor, ionomycin (1 
,uM) applied over 5 h, reduced ET-l secretion to 
11.0 k 1.0% at control extracellular Ca2’ (1.8 mM) and 
to 16.0 k 1.2% in the additional presence of 5 mM 
EGTA (n = 3, data not shown). To ascertain that re- 
duced secretion rates were not due to endothelial cell 
death, viability was judged by visual inspection and ver- 
ified by two different quantitative assays. No change in 
appearance of cells incubated with the different agents 
was noticed. As a measure of cell membrane integrity, 
LDH release was measured in conditioned media. Con- 
trol LDH release was less than 5% of total releasable 
LDH, and enzyme release was not increased in the pres- 
ence of the various agents, including the Ca” iono- 
phores. Identical results were obtained using the modi- 
fied MTT conversion assay, which quantifies release of 
intracellular dehydrogenase activities (data not shown). 
R Brunner et al. IFEBS Letters 350 (1994) 33-36 35 
Control 
50 110 190 420 470 1000>1000 
Wa’+l, WV 
Fig. 3. Relationship between cumulative ET-I secretion over 3 h and 
intracellular free Ca” concentration. ET-I levels were determined on 
separate plates of cells derived from the same aorta as those in which 
Ca” was measured (see ordinate of Fig. 2). Data are means + S.E.M. 
of 7 different determinations. *P < 0.05 vs. control. 
The involvement of nitric oxide in the inhibitory effect 
of A231 87 on ET-I secretion was analyzed at basal and 
stimulated conditions. Neither inhibition of basal secre- 
tion nor secretion stimulated by PMA (0.4 PM) was 
affected by p-nitro-L-arginine (L-NNA, 0.1 mM; 
Fig. 4). 
4. Discussion 
Our study shows that basal ET-l secretion is governed 
by the intracellular free Ca2+ concentration. Depriving 
cells of extracellular Ca2’ decreased ET-l secretion, as 
did manipulations designed to increase [Ca”]i beyond 
resting levels. The Ca2’ ionophores A23 187 and ionomy- 
tin reduced basal and PMA-stimulated ET-l produc- 
tion, and this inhibition was time-dependent. Since both 
ionophores are known to stimulate Cat+ mobilization 
and entry, the simplest interpretation of these data is that 
the Ca” ionophores inhibited ET-l secretion subsequent 
to raised intra~llular Ca2+ levels. The endothelial cells 
used were of first passage to assure a homogeneous pop- 
ulation with highly reproducible peptide secretion rates; 
they released ET-l in a time-dependent manner and at 
rates similar to published reports. On challenge with 
PMA, a well-known secretagogue [S], they responded 
with increased secretion rates as previously reported [7]. 
Under control conditions (1.8 mM extracellular Ca2”), 
[Caz’li was 190 nM, similar to our previous determina- 
tions [ 13,191. When intracellular Ca2+ levels were reduced 
by incubating cells with EGTA, ET-1 secretion was sup- 
pressed, probably due to inhibition of ET-l synthesis or 
processing of proforms. The availability of extracellular 
Ca2’ together with a graded intracellular mobilization by 
thapsigargin [17,201 reproducibly raised [Ca*‘]i up to - 1 
PM, whereas ionomycin (1 PM) increases levels of Ca2’ 
in endothelial cells substantially above 1 ,uM [18]. The 
initial increase in ET-l secretion is consistent with Ca*‘- 
dependent ET-l synthesis and/or processing. This is also 
supported by the pronounced inhibition of ET-l secre- 
tion in the presence of ionomycin and EGTA, a situation 
where the chelator deprives the cells of extracellular and, 
in turn, intracellular Ca”. The concentration- and time- 
dependent inhibition of ET-l secretion observed here 
following 3 h of incubation at high [Ca2’li agrees well 
with a report of diminished ET-l mRNA transcription 
after 2 h of incubation with Ca” ionophore [lo], 
The physical condition of the cells following incuba- 
tion with various agents affecting [Ca2’], is of critical 
importance in the present study. A toxic effect, however, 
cannot explain the reduction in ET-l secretion seen in 
Fig. 3 at either low or high Ca2+ concentrations, since 
incubation over 3 h did not result in toxic intracellular 
Ca2’ levels as evident from several stringent criteria of 
cell viability, which all showed that treated cells were as 
viable as non-treated control cells. Ca2’ ionophores ap- 
plied for as long as 13 h [I l] or 24 h 1211 may, however, 
damage cells and compromize ET production. 
Our findings that ET-l secretion is critically depend- 
ent on [Ca”], may explain the inconsistent effects on 
ET-l secretion obtained with Ca*+ mobilizing agents. 
Thus, angiotensin II was reported to stimulate ET-l se- 
cretion [S] or was without effect [22]. This may be re- 
solved if, given the bell-shaped relationship, the [Ca”], 
were different in the two populations of cells, allowing 
an increase in ET-l secretion [8] or precluding it because 
the maximal rate had already been attained. Similarly, 
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Fig. 4. Effect of L-NNA (0.1 mM) on ET-1 secretion under basal, 
stimulated (PMA, 0.4pM), and A23187-inhibited conditions. Endothe- 
lial cells were incubated for 3 h, and ET-I was measured in cell condi- 
tioned media. Extracellular Ca” concentration was I .8 mM. The data 
aremeans f S.E.M. of 3 different determinations. L-NNA had no effect 
on either condition. 
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the stimulatory effects of A23187 [8,9], the lack of effect 
[12], or the inhibition of secretion (present report) may 
be due to different resting Ca2’ levels. 
It is presently unclear how low and pathophysiologi- 
tally high intracellular Ca*’ levels inhibit ET-l secretion. 
Nitric oxide does not seem to be involved since both 
basal and stimulated ET-l secretion was unaffected by 
L-NNA which inhibits nitric oxide synthase [23]. At low 
intracellular Ca*’ levels, reduced Ca2’-dependent protein 
kinase C activity may be limiting ET synthesis (F. Brun- 
ner, unpublished observation), whereas high levels of 
Ca*’ might suppress ET synthesis to avoid deleterious 
effects on blood vessel tone. 
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